BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2003
View Archived Issues
Valentis and Schering sign multiproduct agreement for gene-based therapeutic products
Read More
Campath enters phase I/II trial in NHL
Read More
Milnacipran demonstrates analgesic efficacy in animal model of FMS
Read More
G17DT granted orphan drug status in Australia for gastric and pancreatic cancers
Read More
Cephalon files sNDA for Provigil
Read More
Olux approved for treatment of psoriasis
Read More
Bicifadine enters phase III for postsurgical dental pain
Read More
Oxigene begins phase II trial of CA4P in thyroid cancer
Read More
CeNeS outlicenses CEE-03-310 to Swiss biopharmaceutical company
Read More
Joint development agreement signed by Beaufour Ipsen and Roche for new anticancer drugs
Read More
Collaboration to develop drugs for atrial fibrillation renewed by ICAgen and BMS
Read More
Novartis files supplemental NDA for Starlix
Read More
Genelabs submits MAA for lupus drug in Europe
Read More
Relpax granted FDA approval
Read More
SuperGen submits first module of rolling NDA for Orathecin
Read More
Genentech and Xoma submit BLA for FDA approval of Raptiva
Read More
Foradil Certihaler filed for approval in the U.S.
Read More
Beneficial long-term effects of arzoxifene on bone and lipids in ovariectomized rats
Read More
Inhibition of tight junction function as a novel approach to breast cancer
Read More
Highly potent, orally available human glucagon receptor antagonist with antihyperglycemic activity
Read More
Potential antileukemia agents selected from series of arsonic acids
Read More
Meiji Seika identifies potent, selective and orally available 5-HT7 receptor antagonist
Read More
Small-molecule GFRalpha-1 agonist mimics effects of GDNF in neuroblastoma cells
Read More
New modulators of glucose and lipid levels designed by Dr. Reddy's researchers
Read More
Humira approved by FDA for RA
Read More
Azido-based photosensitizers covered by Mallinckrodt patent
Read More
Adenine nucleotide translocator-binding compounds and their use reported by MitoKor
Read More
Novel prodrugs of FBPase inhibitors prepared and tested at Metabasis Therapeutics
Read More
Tularik presents new CXCR3 antagonists with utility in restenosis and other disorders
Read More